Effect of hepatitis C virus on the central nervous system of HIV-infected individuals

References

• UNAIDS. Epidemic update. In: Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Joint United Nations Programme on HIV/ AIDS (UNAIDS); 2010. Available from: www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en.pdf. Accessed October 15, 2012.
   Google Scholar
• World Health Organization. Hepatitis C: fact sheet, no. 164. Geneva: World Health Organization; 2012. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/index.html. Accessed October 15, 2012.
   Google Scholar
• Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;32(1):33–46.
   PubMed Web of Science ®Google Scholar
• Hestad K, McArthur JH, Dal Pan GJ, et al. Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand. 1993;88(2):112–118.
   PubMed Web of Science ®Google Scholar
• Hinkin CH, van Gorp WG, Mandelkern MA, et al. Cerebral metabolic change in patients with AIDS: Report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci. 1995;7(2):180–187.
   PubMed Web of Science ®Google Scholar
• Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19(6):517–524.
   PubMed Web of Science ®Google Scholar
• Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol. 1986;19(6):525–535.
   PubMed Web of Science ®Google Scholar
• Forton DM, Allsop JM, Main J, Foster GR, Thomas HC,Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet. 2001;358(9275):38–39.
   PubMed Web of Science ®Google Scholar
• Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35(2):433–439.
   PubMed Web of Science ®Google Scholar
• Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol. 2004;41(5):845–851.
   PubMed Web of Science ®Google Scholar
• Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. JInt NeuropsycholSoc. 2003;9(6):847–854.
   PubMed Web of Science ®Google Scholar
• Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002;35(2):440–446.
   PubMed Web of Science ®Google Scholar
• Kramer L, Bauer E, Funk G, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol. 2002;37(3):349–354.
   PubMed Web of Science ®Google Scholar
• McAndrews MP, Farcnik K, Carlen P, et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology. 2005;41(4):801–808.
   PubMed Web of Science ®Google Scholar
• Huckans M, Seelye A, Parcel T, et al. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc. 2009;15(1):69–82.
   PubMed Web of Science ®Google Scholar
• Kramer L, Hofer H, Bauer E, et al. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. AIDS. 2005;19 Suppl 3:S85-S92.
   Google Scholar
• Cordoba J, Flavia M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol. 2003;39(2):231–238.
   PubMed Web of Science ®Google Scholar
• Fontana RJ, Bieliauskas LA, Back-Madruga C, et al. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol. 2005;43(4):614–622.
   PubMed Web of Science ®Google Scholar
• Lowry D, Coughlan B, McCarthy O, Crowe J. Investigating health- related quality of life, mood and neuropsychological test performance in a homogeneous cohort of Irish female hepatitis C patients. J Viral Hepat. 2010;17(5):352–359.
   PubMed Web of Science ®Google Scholar
• Forton DM, Hamilton G, Allsop JM, et al. Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study. J Hepatol. 2008;49(3):316–322.
   PubMed Web of Science ®Google Scholar
• Karaivazoglou K, Assimakopoulos K, Thomopoulos K, et al. Neuropsychological function in Greek patients with chronic hepatitis C. Liver Int. 2007;27(6):798–805.
   PubMed Web of Science ®Google Scholar
• Aronow HA, Weston AJ, Pezeshki BB, Lazarus TS. Effects of coinfection with HIV and hepatitis C virus on the nervous system. AIDS Read. 2008;18(1):43–48.
   Google Scholar
• Parsons TD, Tucker KA, Hall CD, et al. Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection. AIDS. 2006;20(12):1591–1595.
   PubMed Web of Science ®Google Scholar
• Letendre SL, Cherner M, Ellis RJ, et al. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS. 2005;19 Suppl 3: S72-S78.
   Google Scholar
• Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P; Manhattan HIV Brain Bank. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology. 2004;62(6):957–962.
   PubMed Web of Science ®Google Scholar
• Morgello S, Estanislao L, Ryan E, et al. Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. AIDS. 2005;19 Suppl 3:S116-S122.
   Google Scholar
• Hilsabeck RC, Castellon SA, Hinkin CH. Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clin Infect Dis. 2005; 41 Suppl 1:S38-S44.
   Google Scholar
• Martin EM, Novak RM, Fendrich M, et al. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc. 2004;10(2):298–300.
   PubMed Web of Science ®Google Scholar
• Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ. Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis. 2008;27(2):11–17.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Smurzynski M, Park LS, et al. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology. 2009;73(4):309–314.
   Web of Science ®Google Scholar
• von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, et al. Psychomotor slowing in hepatitis C and HIV infection. JAcquir Immune Defic Syndr. 2004;35(2):131–137.
   PubMed Web of Science ®Google Scholar
• Perry W, Carlson MD, Barakat F, et al. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS. 2005;19 Suppl 3:S79-S84.
   Google Scholar
• Soogoor M, Lynn HS, Donfield SM, et al. Hepatitis C virus infection and neurocognitive function. Neurology. 2006;67(8):1482–1485.
   Web of Science ®Google Scholar
• Anthony IC, Bell JE. The neuropathology of HIV/AIDS. Int Rev Psychiatry. 2008;20(1):15–24.
   PubMed Web of Science ®Google Scholar
• McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005;4(9):543–555.
   PubMed Web of Science ®Google Scholar
• Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS. 2010;24(9):1243–1250.
   PubMed Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–1799.
   PubMed Web of Science ®Google Scholar
• Hazleton JE, Berman JW, Eugenin EA. Novel mechanisms of central nervous system damage in HIV infection. HIV AIDS (Auckl). 2010;2:39–49.
   Google Scholar
• Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nat Rev Neurosci. 2007;8(1):33–44.
   PubMed Web of Science ®Google Scholar
• Heaton RK, Grant I, Butters N, et al. The HNRC 500 - neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995;1(3):231–251.
   PubMedGoogle Scholar
• Stout JC, Salmon DP, Butters N, et al. Decline in working memory associated with HIV infection. HNRC group. Psychol Med. 1995;25(6):1221–1232.
   Web of Science ®Google Scholar
• Marcotte TD, Grant I, Atkinson JH, Heaton RK. Neurobehavioral complications of HIV infection. In: Butters M, Beers SR, editors. Medical Neuropsychology. New York: Kluwer Academic/Plenum Publishers; 2001:85–105.
   Google Scholar
• Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41(6):778–785.
   Google Scholar
• Post MJ, Berger JR, Duncan R, Quencer RM, Pall L, Winfield D. Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long-term MR imaging and clinical follow-up. Radiology. 1993;188(3):727–733.
   Web of Science ®Google Scholar
• Broderick DF, Wippold FJ 2nd, Clifford DB, Kido D, Wilson BS. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol. 1993;161(1):177–181.
   Web of Science ®Google Scholar
• Stout JC, Ellis RJ, Jernigan TL, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV neurobehavioral research center group. Arch Neurol. 1998;55(2):161–168.
   PubMedGoogle Scholar
• Samuelsson K, Pirskanen-Matell R, Bremmer S, HindmarshT, Nilsson BY, Persson HE. The nervous system in early HIV infection: a prospective study through 7 years. Eur J Neurol. 2006;13(3):283–291.
   PubMed Web of Science ®Google Scholar
• Marcus CD, Taylor-Robinson SD, Sargentoni J, et al. 1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities. Metab Brain Dis. 1998;13(2):123–136.
   Web of Science ®Google Scholar
• Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology. 1999;52(5):995–1003.
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology. 1999;52(1):100–108.
   Web of Science ®Google Scholar
• Stankoff B, Tourbah A, Suarez S, et al. Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology. 2001;56(1):112–115.
   Web of Science ®Google Scholar
• Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology. 2004;45(6):549–559.
   Web of Science ®Google Scholar
• Bell JE. The neuropathology of adult HIV infection. Rev Neurol (Paris). 1998;154(12):816–829.
   Web of Science ®Google Scholar
• Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol. 1996;6(1):1–15.
   Web of Science ®Google Scholar
• Sinclair E, Gray F, Ciardi A, Scaravilli F. Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J Neuropathol Exp Neurol. 1994;53(1):43–50.
   Web of Science ®Google Scholar
• Everall I, Vaida F, Khanlou N, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. JNeurovirol. 2009;15(5–6):360–370.
   Web of Science ®Google Scholar
• Ranki A, Nyberg M, Ovod V et al. Abundant expression of HIV nef and rev proteins in brain astrocytes in vivo is associated with dementia. AIDS. 1995;9(9):1001–1008.
   Web of Science ®Google Scholar
• Trillo-Pazos G, Diamanturos A, Rislove L, et al. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003;13(2):144–154.
   PubMed Web of Science ®Google Scholar
• Esiri MM, Morris CS, Millard PR. Fate of oligodendrocytes in HIV-1 infection. AIDS. 1991;5(9):1081–1088.
   Web of Science ®Google Scholar
• Anderson E, Zink W, Xiong H, Gendelman HE. HIV-1-associated dementia: A metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr. 2002;31 Suppl 2:S43-S54.
   Google Scholar
• Lambotte O, Deiva K, Tardieu M. HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol. 2003;13(1):95–103.
   Web of Science ®Google Scholar
• Albright AV, Soldan SS, Gonzalez-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol. 2003;9(2):222–227.
   Web of Science ®Google Scholar
• Kaul M, Lipton SA. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A. 1999;96(14):8212–8216.
   PubMed Web of Science ®Google Scholar
• Johnston JB, Zhang K, Silva C, et al. HIV-1 tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol. 2001;49(2):230–241.
   Web of Science ®Google Scholar
• Power C, McArthur JC, Nath A, et al. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol. 1998;72(11):9045–9053.
   Web of Science ®Google Scholar
• Pu H, Tian J, Flora G, et al. HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol Cell Neurosci. 2003;24(1):224–237.
   PubMed Web of Science ®Google Scholar
• Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues. J Virol. 1997;71(3):2059–2071.
   Web of Science ®Google Scholar
• Dunfee R, Thomas ER, Gorry PR, Wang J, Ancuta P, Gabuzda D. Mechanisms of HIV-1 neurotropism. Curr HIV Res. 2006;4(3):267–278.
   PubMed Web of Science ®Google Scholar
• Dunfee RL, Thomas ER, Gorry PR, et al. The HIV env variant N283 enhances macrophage tropism and is associated with brain infection and dementia. Proc Natl Acad Sci U S A. 2006;103(41):15160–15165.
   Web of Science ®Google Scholar
• Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology. 2001;56(2):257–260.
   PubMed Web of Science ®Google Scholar
• Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 1999;13(10):1249–1253.
   PubMed Web of Science ®Google Scholar
• Tozzi V Balestra P, Bellagamba R, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007;45(2):174–182.
   PubMed Web of Science ®Google Scholar
• Larussa D, Lorenzini P, Cingolani A, et al. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res Hum Retroviruses. 2006;22(5):386–392.
   Web of Science ®Google Scholar
• Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19(2):152–168.
   PubMed Web of Science ®Google Scholar
• Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21(14):1915–1921.
   PubMed Web of Science ®Google Scholar
• Cysique LA, Maruff P, Brew BJ. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/ acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J Neurovirol. 2004;10(6):350–357.
   PubMed Web of Science ®Google Scholar
• McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. 2004;157(1–2):3–10.
   Web of Science ®Google Scholar
• Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–299.
   PubMed Web of Science ®Google Scholar
• Dougherty RH, Skolasky RL Jr, McArthur JC. Progression of HIV- associated dementia treated with HAART. AIDS Read. 2002;12(2):69–74.
   Google Scholar
• Ciccarelli N, Fabbiani M, Di Giambenedetto S, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76(16):1403–1409.
   Web of Science ®Google Scholar
• Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev. 2009;19(2):169–185.
   PubMed Web of Science ®Google Scholar
• Venkataramana A, Pardo CA, McArthur JC, et al. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology. 2006;67(3):383–388.
   PubMed Web of Science ®Google Scholar
• Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol. 2005;11 Suppl 3:16–22.
   Google Scholar
• Poynard T, Cacoub P, Ratziu V, et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat. 2002;9(4):295–303.
   PubMed Web of Science ®Google Scholar
• Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med. 2002;32(1):1–10.
   PubMed Web of Science ®Google Scholar
• Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok AS. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol. 2002;36(3):401–407.
   PubMed Web of Science ®Google Scholar
• Goh J, Coughlan B, Quinn J, O’Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol. 1999;11(8):833–838.
   Web of Science ®Google Scholar
• Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998;27(1):209–212.
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology. 1999;29(1):264–270.
   PubMed Web of Science ®Google Scholar
• Carta MG, Hardoy MC, Garofalo A, et al. Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemiol Ment Health. 2007;3:22.
   PubMedGoogle Scholar
• Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology. 1978;75(3):462–469.
   Web of Science ®Google Scholar
• Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology. 1984;86(6):1421–1427.
   Web of Science ®Google Scholar
• Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis. 2001;16(1–2):13–19.
   Web of Science ®Google Scholar
• Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–721.
   PubMed Web of Science ®Google Scholar
• Forton DM, Taylor-Robinson SD, Thomas HC. Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol. 2006;18(4):333–338.
   PubMed Web of Science ®Google Scholar
• Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol. 2004;41(5):845–851.
   PubMed Web of Science ®Google Scholar
• Forton DM, Thomas HC, Taylor-Robinson SD. Quality of life and cognitive function in chronic hepatitis C - what to measure? J Hepatol. 2003;39(2):272–274.
   Web of Science ®Google Scholar
• Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42 Suppl 1:S45-S53.
   Google Scholar
• Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic hepatitis C: a review. DigDis Sci. 2008;53(2):307–321.
   PubMed Web of Science ®Google Scholar
• Heeren M, Weissenborn K, Arvanitis D, et al. Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. J Cereb Blood Flow Metab. 2011;31(11):2199–2208.
   PubMed Web of Science ®Google Scholar
• Grover VP, Pavese N, Koh SB, et al. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat. 2012;19(2):e89–496.
   PubMed Web of Science ®Google Scholar
• Weissenborn K, Ennen JC, Bokemeyer M, et al. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut. 2006;55(11):1624–1630.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver. 1999;19(5):389–398.
   Google Scholar
• Bokemeyer M, Ding XQ, Goldbecker A, et al. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut. 2011;60(3):370–377.
   PubMed Web of Science ®Google Scholar
• Heeren M, Weissenborn K, Arvanitis D, et al. Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. J Cereb Blood Flow Metab. 2011;31(11):2199–2208.
   PubMed Web of Science ®Google Scholar
• Byrnes V Miller A, Lowry D, et al. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. J Hepatol. 2012;56(3):549–556.
   PubMed Web of Science ®Google Scholar
• Pattullo V, McAndrews MP, Damyanovich A, Heathcote EJ. Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes. Liver Int. 2011;31(7):1028–1038.
   PubMed Web of Science ®Google Scholar
• Kraus MR, Schafer A, Wissmann S, Reimer P, Scheurlen M. Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. Clin Pharmacol Ther. 2005;77(1):90–100.
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Gorman JM, Dieterich DT. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study, AIDS. 2005;19 Suppl 3:S174-S178.
   Google Scholar
• Thein HH, Maruff P, Krahn MD, et al. Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Med. 2007;8(8):520–528.
   PubMed Web of Science ®Google Scholar
• Clifford DB, Evans SR, Yang Y, Gulick RM. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV- infected subjects. AIDS. 2005;19 Suppl 3:S64—S71.
   Google Scholar
• Cherner M, Letendre S, Heaton RK, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology. 2005;64(8):1343–1347.
   PubMed Web of Science ®Google Scholar
• Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52(4):1497–1505.
   PubMed Web of Science ®Google Scholar
• Winston A, Garvey L, Scotney E, et al. Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals? J Viral Hepat. 2010;17(6):419–426.
   Web of Science ®Google Scholar
• Laskus T, Radkowski M, Bednarska A, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002;76(19):10064–10068.
   PubMed Web of Science ®Google Scholar
• Radkowski M, Wilkinson J, Nowicki M, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2002;76(2):600–608.
   PubMed Web of Science ®Google Scholar
• Fishman SL, Murray JM, Eng FJ, Walewski JL, Morgello S, Branch AD. Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis. 2008;197(4):597–607.
   Web of Science ®Google Scholar
• Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol. 2004;78(10):5170–5183.
   Web of Science ®Google Scholar
• Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: Identification of infected cells. J Virol. 2009;83(3):1312–1319.
   PubMed Web of Science ®Google Scholar
• Wilkinson J, Radkowski M, Eschbacher JM, Laskus T. Activation of brain macrophages/microglia cells in hepatitis C infection. Gut. 2010;59(10):1394–1400.
   PubMed Web of Science ®Google Scholar
• Fletcher NF, Yang JP, Farquhar MJ, et al. Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology. 2010;139(4):1365–1374.
   PubMed Web of Science ®Google Scholar
• Burgel B, Friesland M, Koch A, et al. Hepatitis C virus enters human peripheral neuroblastoma cells — evidence for extra-hepatic cells sustaining hepatitis C virus penetration. J Viral Hepat. 2011;18(8):562–570.
   Web of Science ®Google Scholar
• Fletcher NF, Wilson GK, Murray J, et al. Hepatitis C virus infects the endothelial cells of the blood—brain barrier. Gastroenterology. 2012;142(3):634—643. e6.
   Web of Science ®Google Scholar
• Vivithanaporn P, Maingat F, Lin LT, et al. Hepatitis C virus core protein induces neuroimmune activation and potentiates human immunodeficiency virus-1 neurotoxicity. PLoS One. 2010;5(9):e12856.
   Web of Science ®Google Scholar
• Forton DM. Hepatitis C treatment — clearing the mind. J Hepatol. 2012;56(3):513—514.
   Web of Science ®Google Scholar